Search
Amphastar Pharmaceuticals Inc
AMPHAdd to Watchlist
19.640USD
-0.460-2.29%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
876.67MMarket Cap
11.49P/E TTM
More Details of Amphastar Pharmaceuticals Inc Company
Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable, inhalation, and intranasal products. Additionally, it sells insulin API products. Most of its finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers. The Company manufactures and sells over 25 products, such as BAQSIMI (glucagon) nasal powder 3mg, Primatene MIST, Glucagon for Injection Emergency Kit, Enoxaparin, Naloxone and Other Marketed Products, including Cortrosyn (cosyntropin for injection), Amphadase, Epinephrine injection, Lidocaine jelly, Lidocaine topical solution, Phytonadione injection, and others. The Company manufactures and sells two API products, Recombinant Human Insulin (RHI API) and porcine insulin API, for the injectable insulin market.
Amphastar Pharmaceuticals Inc Info
Ticker SymbolAMPH
Company nameAmphastar Pharmaceuticals Inc
IPO dateJun 25, 2014
CEOZhang (Yongfeng Yongfeng)
Number of employees2028
Security typeOrdinary Share
Fiscal year-endJun 25
Address11570 6th St
CityRANCHO CUCAMONGA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code91730
Phone19099809484
Websitehttps://amphastar.com/
Ticker SymbolAMPH
IPO dateJun 25, 2014
CEOZhang (Yongfeng Yongfeng)
Company Executives of Amphastar Pharmaceuticals Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Rong Zhou
Mr. Rong Zhou
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
208.23K
+5.34%
Dr. Howard S. Lee, Ph.D.
Dr. Howard S. Lee, Ph.D.
Independent Director
Independent Director
154.23K
+4.78%
Mr. William J. Peters
Mr. William J. Peters
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
73.11K
+24.17%
Mr. Floyd F. Petersen
Mr. Floyd F. Petersen
Independent Director
Independent Director
66.25K
-3.09%
Mr. Richard K. Prins
Mr. Richard K. Prins
Lead Independent Director
Lead Independent Director
38.20K
+21.31%
Ms. Gayle Deflin
Ms. Gayle Deflin
Independent Director
Independent Director
13.94K
+58.44%
Dr. Yongfeng (Jack) Zhang, Ph.D.
Dr. Yongfeng (Jack) Zhang, Ph.D.
President, Chief Executive Officer, Chief Scientific Officer, Director
President, Chief Executive Officer, Chief Scientific Officer, Director
--
--
Dr. Ziping (Mary) Luo, Ph.D.
Dr. Ziping (Mary) Luo, Ph.D.
Chairman of the Board, Chief Operating Officer, Chief Scientist
Chairman of the Board, Chief Operating Officer, Chief Scientist
--
--
Ms. Diane G. Gerst
Ms. Diane G. Gerst
Independent Director
Independent Director
--
--
Dr. Michael A. Zasloff, M.D., Ph.D.
Dr. Michael A. Zasloff, M.D., Ph.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Rong Zhou
Mr. Rong Zhou
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
208.23K
+5.34%
Dr. Howard S. Lee, Ph.D.
Dr. Howard S. Lee, Ph.D.
Independent Director
Independent Director
154.23K
+4.78%
Mr. William J. Peters
Mr. William J. Peters
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
73.11K
+24.17%
Mr. Floyd F. Petersen
Mr. Floyd F. Petersen
Independent Director
Independent Director
66.25K
-3.09%
Mr. Richard K. Prins
Mr. Richard K. Prins
Lead Independent Director
Lead Independent Director
38.20K
+21.31%
Ms. Gayle Deflin
Ms. Gayle Deflin
Independent Director
Independent Director
13.94K
+58.44%
FAQs
Who are the top five shareholders of Amphastar Pharmaceuticals Inc?
The top five shareholders of Amphastar Pharmaceuticals Inc are: Mr. Rong Zhou
How many institutions hold shares of Amphastar Pharmaceuticals Inc (AMPH)?
As of 2026Q1, 582 institutions hold shares of Amphastar Pharmaceuticals Inc, with a combined market value of approximately 35.15M, accounting for 79.72% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -4414480.00.
What is the biggest source of revenue for Amphastar Pharmaceuticals Inc?
In 2026Q1, the Other products business generated the highest revenue for Amphastar Pharmaceuticals Inc, amounting to 229.65M and accounting for 31.90% of total revenue.